Trials / Completed
CompletedNCT00363844
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
MK-0431/ONO-5435 Phase III Clinical Study - Long-term Treatment Study for Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 209 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sitagliptin phosphate | 50 mg QD or 100 mg QD for 12 months |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-02-01
- First posted
- 2006-08-15
- Last updated
- 2012-06-14
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00363844. Inclusion in this directory is not an endorsement.